Table 1

Characteristics of the study population, classified by HbA1c profile and monitoring completeness

HbA1c profile 1*
Target HbA1c :
53 mmol/mol (7.0%)
HbA1c profile 2†
Target HbA1c :
58 mmol/mol (7.5%)
HbA1c profile 3‡
HbA1c: 64 mmol/mol
(8.0%)
Incomplete
n=3345
Complete
n=6794
Incomplete
n=396
Complete
n=656
Incomplete
n=217
Complete
n=687
HbA1c level: mean (SD)mmol/mol53.51 (12.31)51.56 (10.51)55.91 (11.66)53.87 (10.60)55.12 (10.57)53.60 (8.98)
%7.05 (1.13)6.87 (0.96)7.27 (1.07)7.08 (0.97)7.19 (0.97)7.06 (0.82)
Diabetes duration, years: median (IQR)3 (3–8)7 (4–10)3 (3–7)7 (4–8)13 (11–16)13 (11–15)
Age (years): median (IQR)61 (54–67)62 (55–68)74 (72–76)74 (71–76)74 (72–77)74 (72–76)
Gender: % women (n)44 (1465)46 (3106)46 (183)45 (297)51(110)46 (316)
  • *Profile 1: patients aged <70 years, and older patients with a mild treatment regime (only metformin monotherapy prescription).

  • †Profile 2: patients aged ≥70 years who need more intensive treatment and diagnosed with diabetes <10 years ago.

  • ‡Profile 3: patients aged ≥70 years who need more intensive treatment and diagnosed with diabetes ≥10 years ago.